Madison Asset Management LLC purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 8,818 shares of the semiconductor company's stock, valued at approximately $3,933,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of SNPS. BlackRock Inc. purchased a new stake in shares of Synopsys during the second quarter worth approximately $7,228,099,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in Synopsys in the 2nd quarter valued at $747,400,000. Norges Bank acquired a new stake in Synopsys during the 4th quarter worth $730,197,000. Bank of New York Mellon Corp purchased a new stake in shares of Synopsys during the second quarter worth $692,074,000. Finally, State Street Corp raised its position in shares of Synopsys by 20.6% in the third quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company's stock valued at $4,322,273,000 after buying an additional 1,493,912 shares during the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Synopsys
In related news, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. This trade represents a 19.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares of the company's stock, valued at $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by insiders.
Analyst Ratings Changes
A number of research analysts have weighed in on the stock. Zacks Research raised shares of Synopsys from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, June 30th. Piper Sandler upgraded Synopsys from a "neutral" rating to an "overweight" rating and upped their price target for the company from $450.00 to $550.00 in a research report on Tuesday, June 23rd. Berenberg Bank set a $633.00 price objective on Synopsys in a research report on Wednesday, May 27th. Wells Fargo & Company lowered their price objective on Synopsys from $535.00 to $450.00 and set an "equal weight" rating on the stock in a research note on Tuesday, August 11th. Finally, Stifel Nicolaus upped their target price on Synopsys from $550.00 to $600.00 and gave the company a "buy" rating in a report on Thursday, May 28th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $563.59.
Check Out Our Latest Research Report on Synopsys
Synopsys Stock Performance
Shares of Synopsys stock opened at $397.92 on Friday. The stock has a market capitalization of $76.19 billion, a price-to-earnings ratio of 92.11, a price-to-earnings-growth ratio of 2.36 and a beta of 1.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. The business has a 50-day moving average of $420.85 and a 200 day moving average of $440.51. Synopsys, Inc. has a 12 month low of $366.00 and a 12 month high of $615.79.
Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating the consensus estimate of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The company had revenue of $2.28 billion during the quarter, compared to analysts' expectations of $2.25 billion. During the same quarter last year, the company posted $3.67 EPS. The firm's revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, sell-side analysts forecast that Synopsys, Inc. will post 10.65 earnings per share for the current year.
Synopsys Profile
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
